Century Therapeutics (IPSC)

Century Therapeutics (IPSC) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• IPSC last traded at $1.47, 0.68% on the day.
• Century Therapeutics: P/E -1.4, revenue $114.90M over the last four quarters.
• Over the past year IPSC returned 148.31%; year to date 47.77%.

Updated 2026-11-02 19:50 UTC